BXCL501 + BXCL501 + Placebo film
Phase 2Terminated 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Agitation
Conditions
Agitation, Dementia
Trial Timeline
Feb 8, 2022 → Apr 1, 2022
NCT ID
NCT05276830About BXCL501 + BXCL501 + Placebo film
BXCL501 + BXCL501 + Placebo film is a phase 2 stage product being developed by BioXcel Therapeutics for Agitation. The current trial status is terminated. This product is registered under clinical trial identifier NCT05276830. Target conditions include Agitation, Dementia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05276830 | Phase 2 | Terminated |
Competing Products
20 competing products in Agitation